Molecular Pharmacology: 44 (3)

September 01, 1993; Volume 44,Issue 3

You have access
High affinity amylin binding sites in rat brain.
K Beaumont, M A Kenney, A A Young and T J Rink

Molecular Pharmacology September 1993, 44 (3) 493-497;
You have access
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
K Mackie, W A Devane and B Hille

Molecular Pharmacology September 1993, 44 (3) 498-503;
You have access
Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.
L A Wong and M L Mayer

Molecular Pharmacology September 1993, 44 (3) 504-510;
You have access
Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
M R Probst, S Reisz-Porszasz, R V Agbunag, M S Ong and O Hankinson

Molecular Pharmacology September 1993, 44 (3) 511-518;
You have access
Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
D G Johns, G S Ahluwalia, D A Cooney, H Mitsuya and J S Driscoll

Molecular Pharmacology September 1993, 44 (3) 519-523;
You have access
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
J Linden, H E Taylor, A S Robeva, A L Tucker, J H Stehle, S A Rivkees, J S Fink and S M Reppert

Molecular Pharmacology September 1993, 44 (3) 524-532;
You have access
Alternative transcript of the nonselective-type endothelin receptor from rat brain.
H F Cheng, Y M Su, J R Yeh and K J Chang

Molecular Pharmacology September 1993, 44 (3) 533-538;
You have access
Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
K Miyayasu, J C Mak, M Nishikawa and P J Barnes

Molecular Pharmacology September 1993, 44 (3) 539-544;
You have access
Enkephalin gene transcription in bovine chromaffin cells is regulated by calcium and protein kinase A signal transduction pathways: identification of DNase I-hypersensitive sites.
L MacArthur, K J Koller and L E Eiden

Molecular Pharmacology September 1993, 44 (3) 545-551;
You have access
Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells.
J K Horton, K N Thimmaiah, F C Harwood, J F Kuttesch and P J Houghton

Molecular Pharmacology September 1993, 44 (3) 552-559;
You have access
Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.
K Sterling, J Weaver, K L Ho, L C Xu and E Bresnick

Molecular Pharmacology September 1993, 44 (3) 560-568;
You have access
Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
M A Proll, R B Clark and R W Butcher

Molecular Pharmacology September 1993, 44 (3) 569-574;
You have access
Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
J M Zgombick, L A Borden, T L Cochran, S A Kucharewicz, R L Weinshank and T A Branchek

Molecular Pharmacology September 1993, 44 (3) 575-582;
You have access
Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
J Ellis, M Seidenberg and M R Brann

Molecular Pharmacology September 1993, 44 (3) 583-588;
You have access
Characterization of the alpha 1A-adrenoceptors of guinea pig liver membranes: studies using 5-[3H]methylurapidil.
J A García-Sáinz and M T Romero-Avila

Molecular Pharmacology September 1993, 44 (3) 589-594;
You have access
Benzoquinoid tyrosine kinase inhibitors are potent blockers of cardiac muscarinic receptor function.
A de S Otero and N M Sweitzer

Molecular Pharmacology September 1993, 44 (3) 595-604;
You have access
Lysophospholipid-mediated inhibition of Na+,K(+)-adenosine triphosphatase is a possible mechanism of immunosuppressive activity of cyclosporin A.
R Anderson, M J Smit and C E Van Rensburg

Molecular Pharmacology September 1993, 44 (3) 605-614;
You have access
Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
K Schmidt, P Klatt and B Mayer

Molecular Pharmacology September 1993, 44 (3) 615-621;
You have access
3-Isobutyl-1-methylxanthine inhibits sustained calcium current independently of cyclic AMP in neuronal and endocrine cells.
S M Simasko and S Yan

Molecular Pharmacology September 1993, 44 (3) 622-627;
You have access
Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
N L Harrison, J L Kugler, M V Jones, E P Greenblatt and D B Pritchett

Molecular Pharmacology September 1993, 44 (3) 628-632;
You have access
Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
G A Rogers, W D Kornreich, K Hand and S M Parsons

Molecular Pharmacology September 1993, 44 (3) 633-641;
You have access
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.
D Rampe, B Wible, D Fedida, R C Dage and A M Brown

Molecular Pharmacology September 1993, 44 (3) 642-648;
You have access
Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
M A Castellano, L X Liu, F J Monsma, D R Sibley, G Kapatos and L A Chiodo

Molecular Pharmacology September 1993, 44 (3) 649-656;
You have access
Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits.
C W Luetje, M Piattoni and J Patrick

Molecular Pharmacology September 1993, 44 (3) 657-666;
You have access
Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
G K Wang, R Simon, D Bell, W M Mok and S Y Wang

Molecular Pharmacology September 1993, 44 (3) 667-676;
You have access
Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations.
M Quik, R G Cook, F Revah, J P Changeux and J Patrick

Molecular Pharmacology September 1993, 44 (3) 678-679;
You have access
Notice of retraction.
R J Lukas, L Lucero, T Audhya and G Goldstein

Molecular Pharmacology September 1993, 44 (3) 680;
You have access
Notice of retraction.
M Quik, R Afar, S Geertsen, H el-Bizri, J M Trifaro, T Audhya and G Goldstein

Molecular Pharmacology September 1993, 44 (3) 680; DOI: https://doi.org/10.1124/mol.44.3.680-a

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals